- Issuer ticker
-
ONCY
- Reported as of
-
11 Feb 2026
- Net transaction value
-
+$83,454
- SEC form
-
4
- Accepted by SEC
-
13 Feb 2026, 07:00:23 UTC
Filing notes and source
Key filing fact
Bernd R. Seizinger filed Form 4 for ONCOLYTICS BIOTECH INC (ONCY) on 13 Feb 2026.
Key facts
- This page summarizes Bernd R. Seizinger's Form 4 filing for ONCOLYTICS BIOTECH INC (ONCY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2026, 07:00.
Change
- Previous filing in this sequence was filed on 20 Jan 2026.
- Current net transaction value: +$83,454.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001789042
Primary reporting owner
Seizinger Bernd R.
- Relationship
-
Director
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONCY
transaction
Common Shares
Purchase
- Transaction value
- $49,590
- Shares
- +60,000
- Change %
- +13%
- Price
-
$0.8265
- Shares after
- 526,991
- Date
- 11 Feb 2026
- Ownership
- Direct
ONCY
transaction
Common Shares
Purchase
- Transaction value
- $33,864
- Shares
- +40,000
- Change %
- +7.6%
- Price
-
$0.8466
- Shares after
- 566,991
- Date
- 12 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.